Gene Logic Inc announced the expansion of its European and Asia Pacific operations. Gene Logic has added sales and support staff to its European office, Gene Logic Ltd, based in London, and also hired a business development representative who will be based in Germany. In addition, the Company has established Gene Logic K.K., a wholly owned subsidiary based in Japan, to provide marketing and customer support in Japan.
According to a release, the Company recently reported that 14 per cent and 33 per cent of its total revenue for the period ended June 30, 2004 resulted from pharmaceutical and biotechnology companies based in Europe and Asia Pacific, respectively. With nearly 50 per cent of its revenue generated from non-US based customers, the Company continues to broaden its international presence to better serve existing customers in their home markets and to expand its worldwide customer base. Gene Logic's customers in Europe include Aventis, Novartis, UCB, Boehringer Ingelheim, GlaxoSmithKline and Solvay, and in Asia Pacific include Daiichi, Fujisawa, Mitsubishi, Sankyo, Sumitomo, and Takeda.
Mark D Gessler, chairman and CEO, Gene Logic, commented, " These initiatives, in combination with our recent establishment of a new research team in Cambridge, Massachusetts, continue our strategy of broadening our services offered and companies served to become the service partner of choice for pharmaceutical and biotechnology companies worldwide."